Article
Serum Level of Cytokeratin 18 (M65) as Prognostic Marker of High Cardiovascular Disease Risk in Non-alcoholic Fatty Liver Disease Individuals
2023-06-23
Abstract excerpt
<h4>Background: </h4> and aim: To explore the discriminant accuracy of Cytokeratin 18 (CK18, including M65 and M30 forms) for an elevated fatty liver index (FLI) as a validated proxy of Non-Alcoholic Fatty Liver Disease (NAFLD), and cardiovascular disease (CVD) risk in the general population. <h4>Methods:</h4> Both serum CK18 forms were measured using a commercial immunoassay in randomly selected samples from 312...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f92dde18-dc39-5424-9945-4af5d02f7da1
- DOI
- 10.20944/preprints202306.1654.v1
